GC-072

GC-072 is a 4-oxoquinolizine antibiotic that selectively inhibits bacterial topoisomerase, demonstrating in vitro activity against resistant B. pseudomallei and other select agents. In vivo murine studies show oral administration provides dose-dependent survival benefits in melioidosis models, supporting its research for novel antibacterial therapies against biothreat pathogens.